Trial
NCT03404024
Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Helixmith Co., Ltd.
Collaborators
—
Condition
Ischemic Heart Disease
Intervention
Stage 1-Low dose VM202RY
Why stopped
Company decided not to move forward with this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-25